Nyxoah Archives | Page 9 of 15

Home / Posts tagged Nyxoah (Page 9)

Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference

Mont-Saint-Guibert, Belgium, Nov. 17 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference, which takes place November 29-December 1, 2022, at the Lotte New [...]

Nyxoah Reports Third Quarter 2022 Financial and Operating Results

Mont-Saint-Guibert, Belgium, Nov. 8 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the quarter ended September 30, 2022. Third Quarter 2022 Financial and Operating Highlights Completed 110 of 115 implants in the DREAM U.S. [...]

Nyxoah Announces Change to Board of Directors

Mont-Saint-Guibert, Belgium, Oct. 24 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Raymond Cohen resigned as member of the board of directors of the Company effective October 18, 2022. About Nyxoah Nyxoah is a medical [...]

Nyxoah to Participate in the Jefferies London Healthcare Conference

Mont-Saint-Guibert, Belgium, Oct. 20 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Jefferies London Healthcare Conference, which takes place November 15-17, 2022, at The Waldorf Hilton in London. Olivier [...]

Nyxoah to Release Third Quarter Financial Results on November 8, 2022

Mont-Saint-Guibert, Belgium, Oct. 18 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the third quarter of 2022 on Tuesday, November 8, 2022, after market close. Company management [...]

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), Sept. 30 (Korea Bizwire) – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the belowinformation following the issue of new shares. Share capital: EUR 4,440,069.16 Total number of securities carrying voting rights: 25,846,279 (all ordinary shares) Total number of voting rights (= denominator): 25,846,279 (all [...]

Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference

Mont-Saint-Guibert, Belgium. Aug. 18 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the 17th Annual Wells Fargo Securities Healthcare Conference, which takes place September 7-9, 2022, [...]

Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

Mont-Saint-Guibert, Belgium, Aug. 8 (Korea Bizwire)– Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the second quarter and first half of 2022. Second Quarter 2022 Financial and Operating Highlights [...]

Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test

Mont-Saint-Guibert, Belgium, Aug. 2 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has entered into a distribution agreement with Acurable SL, a venture-backed medical device company developing wearable [...]

Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference

Mont-Saint-Guibert, Belgium, July 27 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will present at the Canaccord Genuity 42nd Annual Growth Conference, which will take place in Boston, Massachusetts, [...]